Guest guest Posted August 16, 2007 Report Share Posted August 16, 2007 Diagnosis and Management of Primary Progressive Multiple Sclerosis Diagnosis and Management of Primary Progressive Multiple Sclerosis Presented by The s Hopkins University School of Medicine The s Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Supported through an educational grant from Genentech, Inc., and Biogen Idec. Release date: July 2007 Expiration date: July 2008 Estimated time to complete activity: 1 hour The s Hopkins University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)^. Physicians should only claim credit commensurate with the extent of their participation in the activity Primary progressive multiple sclerosis (PPMS) affects about 10% of patients with the disease. Clinical data suggests that PPMS is a spectrum of illness, ranging from relapsing-remitting, secondary progressive to primary progressive. Certain clinical features are somewhat more characteristic of PPMS, but it appears to also have quite a bit in common with the other subtypes of the disease. In this program, Drs. Calabresi, Bruce Cree and Racke discuss recent clinical studies, review diagnostic criteria, and describe their own experiences in the diagnosis and management of PPMS. Dr. Calabresi (Program Chair) has received grants, research support, honorarium and, or has consulted for Amgen Inc., Genentech, Inc., Novartis, Teva Pharmaceutical Industries, Neuroscience, Serono, Inc., and Vertex Pharmaceuticals Inc. Dr. Bruce Cree has no relevant conflict of interest to disclose. Dr. Racke has received grants, research support, honorarium and, or has consulted for Berlex, National Institute at Health, National MS Society, NeuroScience, Serono, and Teva Pharmaceutical Industries. © 2007 the s Hopkins University School of Medicine. All rights reserved. Click here to review the complete CME information. LAUNCH PROGRAM http://www.msleaders.org/ms-leaders/cme/msl_primary_progressive.asp? Presented by The s Hopkins University School of Medicine The s Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Supported through an educational grant from Genentech, Inc., and Biogen Idec. Release date: July 2007 Expiration date: July 2008 Estimated time to complete activity: 1 hour The s Hopkins University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity Primary progressive multiple sclerosis (PPMS) affects about 10% of patients with the disease. Clinical data suggests that PPMS is a spectrum of illness, ranging from relapsing-remitting, secondary progressive to primary progressive. Certain clinical features are somewhat more characteristic of PPMS, but it appears to also have quite a bit in common with the other subtypes of the disease. In this program, Drs. Calabresi, Bruce Cree and Racke discuss recent clinical studies, review diagnostic criteria, and describe their own experiences in the diagnosis and management of PPMS. Dr. Calabresi (Program Chair) has received grants, research support, honorarium and, or has consulted for Amgen Inc., Genentech, Inc., Novartis, Teva Pharmaceutical Industries, Neuroscience, Serono, Inc., and Vertex Pharmaceuticals Inc. Dr. Bruce Cree has no relevant conflict of interest to disclose. Dr. Racke has received grants, research support, honorarium and, or has consulted for Berlex, National Institute at Health, National MS Society, NeuroScience, Serono, and Teva Pharmaceutical Industries. © 2007 the s Hopkins University School of Medicine. All rights reserved. Click here to review the complete CME information. LAUNCH PROGRAM http://www.msleaders.org/ms-leaders/cme/msl_primary_progressive.asp? Diagnosis and Management of Primary Progressive Multiple Sclerosis Presented by The s Hopkins University School of Medicine The s Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Supported through an educational grant from Genentech, Inc., and Biogen Idec. Release date: July 2007 Expiration date: July 2008 Estimated time to complete activity: 1 hour The s Hopkins University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)^. Physicians should only claim credit commensurate with the extent of their participation in the activity Primary progressive multiple sclerosis (PPMS) affects about 10% of patients with the disease. Clinical data suggests that PPMS is a spectrum of illness, ranging from relapsing-remitting, secondary progressive to primary progressive. Certain clinical features are somewhat more characteristic of PPMS, but it appears to also have quite a bit in common with the other subtypes of the disease. In this program, Drs. Calabresi, Bruce Cree and Racke discuss recent clinical studies, review diagnostic criteria, and describe their own experiences in the diagnosis and management of PPMS. Dr. Calabresi (Program Chair) has received grants, research support, honorarium and, or has consulted for Amgen Inc., Genentech, Inc., Novartis, Teva Pharmaceutical Industries, Neuroscience, Serono, Inc., and Vertex Pharmaceuticals Inc. Dr. Bruce Cree has no relevant conflict of interest to disclose. Dr. Racke has received grants, research support, honorarium and, or has consulted for Berlex, National Institute at Health, National MS Society, NeuroScience, Serono, and Teva Pharmaceutical Industries. © 2007 the s Hopkins University School of Medicine. All rights reserved. Click here to review the complete CME information. LAUNCH PROGRAM http://www.msleaders.org/ms-leaders/cme/msl_primary_progressive.asp? -------------------------------------------------------------------------------- Get a sneak peek of the all-new AOL.com. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.